4//SEC Filing
SHERMAN JEFFREY W 4
Accession 0001867096-24-000108
CIK 0001867096other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:19 PM ET
Size
5.6 KB
Accession
0001867096-24-000108
Insider Transaction Report
Form 4
SHERMAN JEFFREY W
Director
Transactions
- Award
Common Stock
2024-06-05+50,000→ 164,380 total
Holdings
- 5,400(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock represents a contingent right to receive one share of the Company's common stock. These shares shall vest in full upon the earlier to occur of June 5, 2025 or the date of the Company's next annual meeting of stockholders.
Documents
Issuer
Xeris Biopharma Holdings, Inc.
CIK 0001867096
Entity typeother
Related Parties
1- filerCIK 0001230482
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:19 PM ET
- Size
- 5.6 KB